Skip to content

Drug interactions

Sunitinib + Teniposide

Severity: Moderate

Sunitinib and Teniposide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sunitinib may inhibit P-glycoprotein and increase teniposide exposure, potentially worsening myelosuppression and mucositis. Both agents can independently cause cytopenias.

What this interaction means in plain words

Sunitinib and Teniposide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Possible P-gp inhibition by sunitinib reduces teniposide efflux; additive myelosuppression.

What to do

Monitor blood counts closely and reduce teniposide dose if marked myelosuppression occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sunitinib and Teniposide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sunitinib with Teniposide?

MediHelp rates the interaction as moderate. Sunitinib and Teniposide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sunitinib may inhibit P-glycoprotein and increase teniposide exposure, potentially worsening myelosuppression and mucositis. Both agents can independently cause cytopenias.

How serious is the interaction between Sunitinib and Teniposide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts closely and reduce teniposide dose if marked myelosuppression occurs.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in